Important Business Aspects of Immuno-Oncology: Issues and Controversies
PharmaTalkRadio20 Juni 2017

Important Business Aspects of Immuno-Oncology: Issues and Controversies

Originally recorded during a panel session at the 2017's Immuno-Oncology 360°, Mark Simon of Torreya Partners moderates the conversation around issues, controversies, and other important business aspects of IO. He's joined by IO360° lead advisor and SVP at GSK, Dr Axel Hoos, Dr Robert Ang of Neon Therapeutics, Dr Jeffrey Bockman from Defined Health, Dr Jeffrey Legos from Novartis Pharmaceuticals, and Dr Chandra Ramanathan at Bayer Healthcare. Save the date for the 4th annual IO360° conference, taking place February 7-9, 2018 in New York City.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(461)

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
allt-du-velat-veta
kapitalet-en-podd-om-ekonomi
rss-ufobortom-rimligt-tvivel
svd-nyhetsartiklar
rss-vetenskapsradion
det-morka-psyket
rss-spraket
paranormalt-med-caroline-giertz
sexet
halsorevolutionen
rss-vetenskapsradion-2
rss-odla
rss-broccolipodden-en-podcast-som-inte-handlar-om-broccoli
medicinvetarna
dumforklarat
rss-ronden
rss-italiensk-dagbok
vetenskapsradion